Procaterol Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01366 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 26 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | open-angle glaucoma | KG + DL |
| 2 | primary hereditary glaucoma | KG + DL |
| 3 | bronchitis | KG + DL |
| 4 | anaphylaxis | KG + DL |
| 5 | food-dependent exercise-induced anaphylaxis | KG + DL |
| 6 | glaucoma 1, open angle | KG + DL |
| 7 | pulmonary emphysema | KG + DL |
| 8 | respiratory malformation | KG + DL |
| 9 | multiple system atrophy | KG + DL |
| 10 | Rienhoff syndrome | KG + DL |
| 11 | obstructive lung disease | KG + DL |
| 12 | variably protease-sensitive prionopathy | KG + DL |
| 13 | hyperthyroidism | KG + DL |
| 14 | sinoatrial block | KG + DL |
| 15 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 16 | obsolete rare pulmonary disease | KG + DL |
| 17 | Jeune syndrome situs inversus | KG + DL |
| 18 | headache disorder | KG + DL |
| 19 | sinoatrial node disease | KG + DL |
| 20 | bronchial disease | KG + DL |
| 21 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 22 | orofacial clefting syndrome | KG + DL |
| 23 | disorder of fucoglycosan synthesis | KG + DL |
| 24 | trigeminal autonomic cephalalgia | KG + DL |
| 25 | Laubry-Pezzi syndrome | KG + DL |
| 26 | partial deletion of the long arm of chromosome 22 | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.